SEC Filings

$

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Hero Chart
Filing date Form Description Filing Group Issuer View
4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc. View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
Mirum Pharmaceuticals, Inc. View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc. View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
Mirum Pharmaceuticals, Inc. View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
Mirum Pharmaceuticals, Inc. EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
Mirum Pharmaceuticals, Inc. View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
Mirum Pharmaceuticals, Inc. View HTML
DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Registration Statements
Mirum Pharmaceuticals, Inc. View HTML
UPLOAD

UPLOAD

Other
Mirum Pharmaceuticals, Inc. View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
Mirum Pharmaceuticals, Inc. View HTML

Data provided by Kaleidoscope.